Shares of Salarius Pharmaceuticals, Inc. SLRX saw a substantial uptick in pre-market trading today after the release of their fourth-quarter results.

Salarius Pharmaceuticals reported a net loss of $0.9 million, or 22 cents per share for the fourth quarter. This is a marked improvement from the year-ago loss of $6.4 million, or $2.83 per share, according to data from Benzinga Pro.

The exuberance continued as Salarius Pharmaceuticals shares soared by 31.4% to $0.8149 in pre-market trading.

Excitement ripples through pre-market trading as other stocks show significant movement.

Winners

• Next.e.GO N.V. EGOX witnessed an 85.8% surge to $0.0730 in pre-market trading after a 22% dip on Friday.
• MicroAlgo Inc. MLGO rose by 56.7% to $6.30 in pre-market trading following a 5% decline on Friday.
• Forge Global Holdings, Inc. FRGE experienced a 22.8% uptick to $2.86 in pre-market trading after a 13% gain on Friday.
• Canopy Growth Corporation CGC climbed 19.5% to $9.17 in pre-market trading. The German government’s approval of cannabis legislation from April 1 has investors buzzing.
• Flora Growth Corp. FLGC saw a 17.7% increase to $1.86 in pre-market trading after a 34% surge on Friday.
• Cazoo Group Ltd CZOO rose by 17.3% to $4.35 in pre-market trading despite a 21% decline on Friday.
• Biophytis S.A. BPTS ascended by 17.1% to $0.4471 in pre-market trading. Biophytis showcased its Phase 3 protocol of RuvembriTM at the ICFSR, boosting confidence in the stock.
• Recon Technology, Ltd. RCON witnessed a 14.5% jump to $0.1570 in pre-market trading.
• Esperion Therapeutics, Inc. ESPR gained 12.7% to $2.58 in pre-market trading as the U.S. FDA expanded labels for their NEXLETOL® and NEXLIZET® drugs, signaling a broader market potential.

Losers

• Sintx Technologies, Inc. SINT plummeted by 29.7% to $0.0650 in pre-market trading following a 32% drop on Friday due to a proposed public offering of common stock.
• Invivyd, Inc. IVVD declined by 14.8% to $3.72 in pre-market trading after a 41% spike on Friday triggered by FDA’s emergency use authorization for PEMGARDA against COVID-19.
• Greenlane Holdings, Inc. GNLN dropped by 10.8% to $0.52 in pre-market trading post an 11% rise on Friday.
• BYND Cannasoft Enterprises Inc. BCAN lost 10.8% to $2.24 in pre-market trading after a 31% fall on Friday.
• Mangoceuticals, Inc. MGRX shares stumbled by 9.7% to $0.1688 in pre-market trading following a 5% decline on Friday.
• Australian Oilseeds Holdings Limited COOT fell by 8.5% to $2.27 in pre-market trading after a 22% fall on Friday.
• Ontrak, Inc. OTRK dipped by 8.2% to $0.36 in pre-market trading following a 50% rise on Friday.
• Murano Global Investments Plc MRNO shares fell by 7.6% to $19.64 in pre-market trading amidst volatility post the company’s business combination with HCM Acquisition Corp and Nasdaq debut.
• Laser Photonics Corporation LASE shares slid by 6.5% to $1.73 in pre-market trading after a 9% dip on Friday, linked to the distribution agreement with Incredible Supply & Logistics (ISL).
• OKYO Pharma Limited OKYO saw a 6.2% decline to $1.44 after a 13% fall on Friday. OKYO Pharma disclosed pivotal findings from the Phase 2 trial evaluating OK-101 (0.05%) ophthalmic solution for dry eye disease (DED).

Now Read This: Top 5 Consumer Stocks That May Crash This Month